Predicting refeeding hypophosphataemia: insulin growth factor 1 (IGF-1) as a diagnostic biochemical marker for clinical practice

Annals of Clinical Biochemistry

Volumn 52, Issue 1, 2015, Pages 82-87

  Goyale, Atul ^a   Ashley, Sarah L ^a   Taylor, David R ^a   Elnenaei, Manal O ^a   Alaghband Zadeh, Jamshid ^a   Sherwood, Roy A ^a   le Roux, Carel W ^b   Vincent, Royce P ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

insulin like growth factor 1; leptin; refeeding hypophosphataemia; Refeeding syndrome

Indexed keywords

LEPTIN; PHOSPHATE; SOMATOMEDIN C; BIOLOGICAL MARKER; IGF1 PROTEIN, HUMAN;

ADULT; ARTICLE; ASSAY; BIOCHEMISTRY; BLOOD SAMPLING; CLINICAL PRACTICE; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PARENTERAL NUTRITION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFEEDING; REFEEDING HYPOPHOSPHATEMIA; REFEEDING SYNDROME; RISK; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; BLOOD; CLINICAL TRIAL; MALNUTRITION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPOPHOSPHATEMIA; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; MALNUTRITION; MIDDLE AGED; PARENTERAL NUTRITION; PROGNOSIS; PROSPECTIVE STUDIES; REFEEDING SYNDROME; ROC CURVE;

EID: 84918780793     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563214523739     Document Type: Article

References (12)

1. Weinsier RL,Krumdieck CL.Death resulting from overzealous total parenteral nutrition: the refeeding syndrome revisited.Am J Clin Nutr. 1981;34:393-399
2. National Institute for Health and Clinical Excellence. Nutrition support in adults. Clinical guideline CG32. 2006.
3. Hearing SD.Refeeding syndrome.Br Med J. 2004;328:908-909
4. Crook MA,Hally V,Panteli JV.The importance of the refeeding syndrome.Nutrition. 2001;17:632-637
5. Marinella MA.The refeeding syndrome and hypophosphatemia.Nutr Rev. 2003;61:320-323
6. Elnenaei MO,Alaghband-Zadeh J,Sherwood RA, et al.Leptin and insulin growth factor 1: diagnostic markers of the refeeding syndrome and mortality.Br J Nutr. 2011;106:906-912
7. Marik PE,Bedigian MK.Refeeding hypophosphatemia in critically ill patients in an intensive care unit.A prospective study. Arch Surg. 1996;131:1043-1047
8. Zeki S,Culkin A,Gabe SM, et al.Refeeding hypophosphataemia is more common in enteral than parenteral feeding in adult in patients.Clin Nutr. 2011;30:365-368
9. Brabant G,von zur Mühlen A,Wüster C.Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study.Horm Res. 2003;60:53-60
10. Holzinger U,Kitzberger R,Fuhrmann V, et al.Correlation of calculated indices of insulin resistance (QUICKI and HOMA) with the euglycaemic hyperinsulinaemic clamp technique for evaluating insulin resistance in critically ill patients.Eur J Anaesthesiol. 2007;24:966-970
11. Schofield WN.Predicting basal metabolic rate, new standards and review of previous work.Hum Nutr Clin Nutr. 1985;39:5-41
12. Dewar H,Horvath RA pocket guide to clinical nutrition. 3rd ed. Worksop, Nottinghamshire: British Dietetic Association, 2007.Todorovic VEMicklewright A, ed. Worksop, Nottinghamshire: British Dietetic Association; 2007: